Heart Failure Systolic
📧 Sign up to get email alerts when something new happens for Heart Failure Systolic.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-11EMA Authorised: Edistride (dapagliflozin propanediol monohydrate) — AstraZeneca AB
Edistride, containing dapagliflozin propanediol monohydrate, has been authorised for treatment in type 2 diabetes, systolic heart failure, h…
-
EMA approval · 2026-06-11EMA Authorised: Forxiga (dapagliflozin propanediol monohydrate) — AstraZeneca AB
Forxiga (dapagliflozin propanediol monohydrate) has been authorised for use in the European Medicines Agency, with indications including Typ…